已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Vaseegara完成签到 ,获得积分10
刚刚
溯洄源点发布了新的文献求助10
2秒前
蛙蛙完成签到,获得积分0
3秒前
seuu关注了科研通微信公众号
3秒前
X57完成签到 ,获得积分10
4秒前
4秒前
hhh完成签到 ,获得积分10
6秒前
Joif发布了新的文献求助10
6秒前
我是老大应助科研通管家采纳,获得10
7秒前
ding应助科研通管家采纳,获得10
7秒前
7秒前
852应助科研通管家采纳,获得10
7秒前
英姑应助科研通管家采纳,获得10
7秒前
上官若男应助科研通管家采纳,获得10
7秒前
无花果应助科研通管家采纳,获得10
7秒前
李健的小迷弟应助科研狗采纳,获得10
7秒前
充电宝应助科研通管家采纳,获得10
7秒前
天天快乐应助科研通管家采纳,获得10
7秒前
7秒前
8秒前
开心快乐水完成签到 ,获得积分10
8秒前
cdercder应助标致的灵槐采纳,获得10
9秒前
9秒前
10秒前
充电宝应助Jian采纳,获得10
10秒前
Ken921319005发布了新的文献求助10
11秒前
拼搏的鹰完成签到,获得积分20
12秒前
16秒前
汉堡包应助zz采纳,获得10
19秒前
万能小包发布了新的文献求助10
19秒前
qqqyoyoyo完成签到,获得积分10
20秒前
XGP完成签到,获得积分10
20秒前
科研通AI6.4应助Ken921319005采纳,获得10
23秒前
wanci应助Ken921319005采纳,获得10
23秒前
潇洒的浩然完成签到,获得积分10
23秒前
阳光谷雪完成签到 ,获得积分20
23秒前
汉堡包应助溯洄源点采纳,获得10
24秒前
荔枝完成签到,获得积分10
26秒前
26秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Direct and Iterative Linear System Solvers 500
Plato's Parmenides. A Constructive Reading 500
Vander's Renal Physiology第10版 500
Poetics of Cognition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7304298
求助须知:如何正确求助?哪些是违规求助? 8922404
关于积分的说明 18901399
捐赠科研通 6967819
什么是DOI,文献DOI怎么找? 3212094
关于科研通互助平台的介绍 2380918
邀请新用户注册赠送积分活动 2189356